TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,529,870 | -65.1% | 2,933,826 | +3.6% | 0.00% | -62.5% |
| Q2 2023 | $70,311,854 | +74.5% | 2,830,589 | +5.6% | 0.01% | +60.0% |
| Q1 2023 | $40,304,207 | +131634.6% | 2,679,800 | +3.6% | 0.01% | +25.0% |
| Q4 2022 | $30,595 | -99.8% | 2,586,273 | +7.3% | 0.00% | +100.0% |
| Q3 2022 | $14,269,000 | +44.5% | 2,410,439 | +3.7% | 0.00% | +100.0% |
| Q2 2022 | $9,875,000 | -52.6% | 2,323,604 | +6.2% | 0.00% | -66.7% |
| Q1 2022 | $20,812,000 | -52.6% | 2,188,471 | -5.3% | 0.00% | -40.0% |
| Q4 2021 | $43,886,000 | -42.7% | 2,309,837 | +0.3% | 0.01% | -50.0% |
| Q3 2021 | $76,623,000 | -8.4% | 2,302,378 | +6.8% | 0.01% | -16.7% |
| Q2 2021 | $83,657,000 | -15.2% | 2,156,676 | +5.3% | 0.01% | -20.0% |
| Q1 2021 | $98,686,000 | +6.7% | 2,047,432 | +15.1% | 0.02% | -6.2% |
| Q4 2020 | $92,511,000 | +112.9% | 1,778,387 | +9.5% | 0.02% | +77.8% |
| Q3 2020 | $43,454,000 | +48.7% | 1,623,842 | +8.2% | 0.01% | +50.0% |
| Q2 2020 | $29,230,000 | +121.6% | 1,500,547 | +11.9% | 0.01% | +100.0% |
| Q1 2020 | $13,190,000 | -46.0% | 1,340,533 | -39.1% | 0.00% | 0.0% |
| Q4 2019 | $24,436,000 | +290.2% | 2,201,606 | +97.4% | 0.00% | +200.0% |
| Q3 2019 | $6,262,000 | -30.0% | 1,115,345 | +7.8% | 0.00% | -50.0% |
| Q2 2019 | $8,949,000 | +19.9% | 1,034,629 | +11.5% | 0.00% | 0.0% |
| Q1 2019 | $7,462,000 | +20.5% | 928,149 | -38.5% | 0.00% | +100.0% |
| Q4 2018 | $6,192,000 | +61.5% | 1,510,410 | +120.6% | 0.00% | 0.0% |
| Q3 2018 | $3,834,000 | -50.5% | 684,807 | +16.3% | 0.00% | -50.0% |
| Q2 2018 | $7,744,000 | +9.5% | 588,930 | +18.2% | 0.00% | 0.0% |
| Q1 2018 | $7,075,000 | +86.7% | 498,251 | +7.8% | 0.00% | +100.0% |
| Q4 2017 | $3,790,000 | -29.5% | 462,270 | +1.9% | 0.00% | -50.0% |
| Q3 2017 | $5,374,000 | +24.1% | 453,571 | +5.3% | 0.00% | 0.0% |
| Q2 2017 | $4,329,000 | +2.6% | 430,754 | +18.9% | 0.00% | 0.0% |
| Q1 2017 | $4,221,000 | +211.5% | 362,353 | +24.3% | 0.00% | +100.0% |
| Q4 2016 | $1,355,000 | -37.9% | 291,602 | +3.4% | 0.00% | 0.0% |
| Q3 2016 | $2,183,000 | +29.9% | 282,125 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $1,680,000 | -28.8% | 277,277 | +0.1% | 0.00% | 0.0% |
| Q1 2016 | $2,361,000 | -21.3% | 277,119 | +10.1% | 0.00% | -50.0% |
| Q4 2015 | $3,001,000 | +20.3% | 251,602 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $2,495,000 | -38.5% | 247,616 | +1.2% | 0.00% | 0.0% |
| Q2 2015 | $4,059,000 | +35.4% | 244,720 | +26.3% | 0.00% | 0.0% |
| Q1 2015 | $2,998,000 | +3.0% | 193,698 | +5.3% | 0.00% | 0.0% |
| Q4 2014 | $2,912,000 | +54.8% | 183,886 | +4.3% | 0.00% | +100.0% |
| Q3 2014 | $1,881,000 | +14.8% | 176,313 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,638,000 | +56.1% | 174,507 | +14.7% | 0.00% | 0.0% |
| Q1 2014 | $1,049,000 | +206.7% | 152,167 | +73.5% | 0.00% | – |
| Q4 2013 | $342,000 | -22.4% | 87,707 | +1.3% | 0.00% | – |
| Q3 2013 | $441,000 | +267.5% | 86,604 | +360.9% | 0.00% | – |
| Q2 2013 | $120,000 | – | 18,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |